
A retrospective analysis of 303 intracerebral hemorrhage (ICH) patients treated from May 2018 to May 2023 was conducted to explore the association between RDWLR and hematoma expansion. The study found that hematoma expansion occurred in 24.1% of cases. Multivariate analysis identified baseline hematoma volume, admission systolic blood pressure, Glasgow Coma Scale (GCS), and RDWLR as significant predictors of hematoma expansion. These findings suggest RDWLR could be a valuable inflammatory biomarker for early prediction of hematoma expansion in ICH patients.
Like
Save
Share